Guangzhou Wondfo Biotech Co.,Ltd (SHE:300482)
China · Delayed Price · Currency is CNY 18.59
-0.16 (-0.85%)
May 15, 2026, 10:35 AM CST
SHE:300482 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Dec '21 Dec 31, 2021 |
Net Income | -167.76 | -63.02 | 561.63 | 487.62 | 1,197 | 634.43 |
Depreciation & Amortization | 229.96 | 229.96 | 272.31 | 277.11 | 270.31 | 203.64 |
Other Amortization | 38.54 | 38.54 | 4.2 | 4.72 | 6.87 | 7.04 |
Loss (Gain) From Sale of Assets | -0.32 | -0.32 | -0.76 | -0.08 | 10.4 | 0.01 |
Asset Writedown & Restructuring Costs | 17.28 | 17.28 | 5.96 | 14.72 | 72.61 | 16.21 |
Loss (Gain) From Sale of Investments | -53.43 | -53.43 | -27.67 | -51.68 | -72.84 | -58.02 |
Provision & Write-off of Bad Debts | -1.24 | -1.24 | 35.72 | 3.18 | 17.05 | 19.95 |
Other Operating Activities | 504.32 | 32.62 | 31.55 | 27.46 | 31.04 | 46.73 |
Change in Accounts Receivable | 271.58 | 271.58 | -571.45 | -69.64 | -137.64 | -273.21 |
Change in Inventory | 70.34 | 70.34 | -12.23 | 41.95 | -21.29 | -14.05 |
Change in Accounts Payable | -134.93 | -134.93 | 87.04 | -412.32 | 296.03 | 36.74 |
Change in Other Net Operating Assets | 106.42 | 106.42 | -0.42 | 9.88 | -0.65 | 43.19 |
Operating Cash Flow | 830 | 463.04 | 361.71 | 328.68 | 1,682 | 664.93 |
Operating Cash Flow Growth | 732.50% | 28.01% | 10.05% | -80.46% | 152.98% | -37.38% |
Capital Expenditures | -276.84 | -304.55 | -318.21 | -432.73 | -583.19 | -456.49 |
Sale of Property, Plant & Equipment | 0.45 | 0.45 | 0.06 | 0.79 | 0.38 | 0.05 |
Cash Acquisitions | - | - | -10.44 | -10.99 | -137.04 | - |
Divestitures | 1.01 | 1.01 | - | - | -7.67 | 5.41 |
Investment in Securities | -132.73 | -163.08 | -744.98 | 270.02 | -890.58 | -371.61 |
Other Investing Activities | 57.61 | 48.7 | 56.97 | 59.51 | 57.2 | 37.21 |
Investing Cash Flow | -350.5 | -417.46 | -1,017 | -113.4 | -1,561 | -785.43 |
Short-Term Debt Issued | - | 0.01 | 0.76 | - | - | 22.68 |
Long-Term Debt Issued | - | 6.73 | 18.05 | 29.42 | 246.91 | 30.24 |
Total Debt Issued | 6.74 | 6.74 | 18.81 | 29.42 | 246.91 | 52.92 |
Short-Term Debt Repaid | - | - | -0 | -204.2 | -12.89 | -99.36 |
Long-Term Debt Repaid | - | -7.45 | -23.54 | -23.61 | -68.18 | -44.07 |
Total Debt Repaid | -7.45 | -7.45 | -23.54 | -227.81 | -81.06 | -143.43 |
Net Debt Issued (Repaid) | -0.71 | -0.71 | -4.74 | -198.39 | 165.85 | -90.51 |
Issuance of Common Stock | - | - | 864.08 | 21.59 | - | 33.8 |
Repurchase of Common Stock | -202.26 | -202.26 | -11.06 | -30.1 | -41.8 | -52.17 |
Common Dividends Paid | -197.64 | -197.64 | -196.16 | -227.95 | -140.48 | -173.74 |
Other Financing Activities | -11.31 | -9.73 | -13.05 | -107.18 | 51.76 | 11.68 |
Financing Cash Flow | -411.92 | -410.34 | 639.08 | -542.02 | 35.33 | -270.94 |
Foreign Exchange Rate Adjustments | -2.96 | -1.34 | 4.33 | 5.88 | 8.63 | -20.25 |
Net Cash Flow | 64.62 | -366.1 | -11.47 | -320.86 | 165.22 | -411.68 |
Free Cash Flow | 553.16 | 158.49 | 43.5 | -104.05 | 1,099 | 208.44 |
Free Cash Flow Growth | - | 264.35% | - | - | 427.24% | -67.55% |
Free Cash Flow Margin | 29.61% | 7.60% | 1.42% | -3.76% | 19.35% | 6.20% |
Free Cash Flow Per Share | 1.15 | 0.33 | 0.09 | -0.23 | 2.49 | 0.47 |
Cash Income Tax Paid | 58.02 | 105.58 | 143.57 | 160.83 | 193.19 | 147.55 |
Levered Free Cash Flow | 153.86 | 4.94 | 107.49 | -327.1 | 651.81 | -32.29 |
Unlevered Free Cash Flow | 173.27 | 24.4 | 126.54 | -308.4 | 672.15 | -14.95 |
Change in Working Capital | 262.65 | 262.65 | -521.23 | -434.37 | 149.67 | -205.04 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.